Aurora Cannabis Inc. ACB
Regular-session close
After hours · Nov 20, 7:25 PM ET
- YTD
- -1.42%
- 1 year
- +1.96%
5D -0.55 (-11.48%)
- Market cap
- 273.50M
- Revenue (ttm)
- 296.99M
- Profit margin
- -14.71%
- EPS (ttm)
- -0.19
- Shares out
- 54.88M
- Forward P/E
- -38.82
- YTD return
- -1.42%
- 1-year return
- +1.96%
- Volume
- 900.39K
- Avg volume
- 1.32M
- Open
- 4.26
- Previous close
- 4.26
- Day's range
- 4.15 – 4.34
- 52-week range
- 2.56 – 6.36
- Beta
- 2.70
- Analysts
- Buy
Key statistics
- 50-day average
- 4.88
- 200-day average
- 5.62
- Enterprise value
- 233.55B
- Price / sales
- 0.79
- Price / book
- 427.00
- Revenue growth
- 28.50%
- Free cash flow
- -84.08M
- Total cash
- 84.92M
- Total debt
- 100.97M
- Return on equity
- -5.79%
Fundamental scorecard
6 of 25 checks passed on ACB’s reported financials
6of 25 checks passed
- Value 0 of 5
- Growth 2 of 5
- Profitability 1 of 5
- Financial health 3 of 5
- Dividend No data
Statements to Sep 30, 2026.
Financials — quick view
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Feb 13, 2025 | Dec 1, 2024 | 0.04 | — | — | — |
| Nov 6, 2024 | Sep 1, 2024 | -0.22 | 0.04 | +0.26 | +118.18% |
| Aug 7, 2024 | Jun 1, 2024 | -0.35 | -0.11 | +0.24 | +68.57% |
| Aug 7, 2024 | Jun 1, 2024 | -0.35 | — | — | — |
| Jun 20, 2024 | Mar 1, 2024 | -0.18 | 0.11 | +0.29 | +161.11% |
| Jun 20, 2024 | Mar 1, 2024 | -0.18 | — | — | — |
About Aurora Cannabis Inc.
Aurora Cannabis Inc., together with its subsidiaries, engages in the production, distribution, and sale of cannabis and cannabis-derivative products in Canada and internationally. It operates through two segments, Canadian Cannabis and Plant Propagation. The company offers medical and consumer cannabis products; supplies propagated vegetables and ornamental plants; and distributes and sells hemp-derived cannabidiol (CBD) products. The company also cultivates and sells dried cannabis, cannabis oils, capsules, edible cannabis, cannabis extracts, and soft gels, which are ingested in various ways, including smoking, vaporizing, and consumption in the form of oil, capsules, dried flowers, vapes, dried milled strains, edibles, concentrates, and strain specific cannabis oils and extracts; and provides patient counseling and outreach services. Its adult-use brand portfolio includes Aurora Drift, San Rafael '71, Daily Special, Whistler, Being, and Greybeard, as well as CBD brands, Reliva and KG7; and medical cannabis brands include MedReleaf, CanniMed, Aurora, Whistler Medical Marijuana Co, Pedanios, Bidiol, and CraftPlant. The company was founded in 2013 and is headquartered in Edmonton, Canada.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Country
- Canada
- Website
- auroramj.com
News
Why Didn't Tilray Brands Make a Bid for Aurora Cannabis?
The Big Winner From the Aurora Cannabis-Organigram Deal: Curaleaf
Aurora Cannabis Inc. (ACB) Q2 Earnings and Revenues Top Estimates Aurora Cannabis Q2 EPS $(0.32) Misses $(0.09) Estimate, Sales $86.021M Beat $72.167M Estimate
Aurora Cannabis Announces Fiscal 2027 Second Quarter Results
Aurora Cannabis Stock: What Organigram's Buyout Means for Investors
Curaleaf Issues Statement Regarding Alternative Proposal for Aurora Cannabis
Aurora Cannabis Stock Surges on Organigram Deal
12 Health Care Stocks Moving In Tuesday's Intraday Session
Organigram to Acquire Aurora and Establish a Global Cannabis Leader
Your note
Sign in to keep a note on ACB — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| Beauchamp (Norma) | Director of Issuer | Acquisition or disposition in the public market | Nov 14, 2022 | 2,595 |
| Clark (Nathalie) | Senior Officer of Issuer | Acquisition or disposition in the public market | Jun 6, 2022 | 2,700 |
| Funk, Ronald | Director of Issuer | Acquisition or disposition in the public market | Jun 6, 2022 | 56,752 |
| Ibbott William Glen | Senior Officer of Issuer | Acquisition or disposition in the public market | Jun 6, 2022 | 43,048 |
| Jerome (Andre) | Senior Officer of Issuer | Exercise of rights | Nov 22, 2022 | 35,052 |
| Kohli (Chitwant S) | Director of Issuer | Acquisition or disposition in the public market | May 30, 2022 | 60,000 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Tidal Investments, LLC | 2.45% | 1,344,321 | 5.74M | Sep 29, 2024 |
| Renaissance Technologies, LLC | 1.20% | 658,255 | 2.81M | Sep 29, 2024 |
| Goldman Sachs Group Inc | 0.73% | 402,814 | 1.72M | Sep 29, 2024 |
| Morgan Stanley | 0.36% | 194,820 | 831.88K | Sep 29, 2024 |
| Susquehanna International Group, LLP | 0.29% | 159,051 | 679.15K | Sep 29, 2024 |
| Jane Street Group, LLC | 0.24% | 129,343 | 552.29K | Sep 29, 2024 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Amplify ETF Tr-Amplify Alternative Harvest ETF | 2.45% | 1,341,643 | 5.73M | Sep 29, 2024 |
| DFA Investment Dimensions-Canadian Small Company Series | 0.11% | 61,293 | 261.72K | Jul 30, 2024 |
| SPDR (R) Idx Shares-SPDR (R) S&P (R) International Small Cap ETF | 0.08% | 45,349 | 193.64K | Sep 29, 2024 |
| Fidelity NASDAQ Composite Index Fund | 0.06% | 32,486 | 138.72K | Oct 30, 2024 |
| DFA International Core Equity Portfolio | 0.03% | 14,401 | 61.49K | Jul 30, 2024 |
| SPDR Portfolio Developed World ex-US ETF | 0.01% | 7,232 | 30.88K | Sep 29, 2024 |
